Literature DB >> 6175659

Enhanced transfer of experimental allergic encephalomyelitis with Lewis rat lymph node cells.

J R Richert, M W Kies, E C Alvord.   

Abstract

Lewis rat lymph node cells (LNC) are greatly enhanced in their ability to transfer experimental allergic encephalomyelitis (EAE) after culture with myelin basic protein (BP). As few as 10(6) LNC transfer disease after culture with antigen. In contrast to spleen cells, enhanced transfer with LNC is not seen after culture with concanavalin A. Neither cell homogenates nor culture supernatants were capable of transferring EAE. Removal of B-cells had no adverse effect on disease transfer. LNC capable of enhanced transfer were found in rats after recovery from, as well as at the height of, clinical disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6175659     DOI: 10.1016/0165-5728(81)90044-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

1.  The clotting system: gatekeeper of cerebrovascular permeability and monitor of clinical manifestations of neuroautoimmune disease.

Authors:  P Y Paterson; J Gausas; C S Koh; H C Kwaan
Journal:  Trans Am Clin Climatol Assoc       Date:  1986

2.  A new model for multiple sclerosis: chronic experimental allergic encephalomyelitis induced by immunization with cerebral endothelial cell membrane.

Authors:  N Tsukada; C S Koh; N Yanagisawa; A Okano; W M Behan; P O Behan
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

3.  Autoimmune encephalomyelitis in rhesus monkeys induced by immunization with cerebral endothelial cell membrane.

Authors:  N Tsukada; C S Koh; N Yanagisawa; A Okano; T Taketomi
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

4.  Antigenized antibodies expressing Vbeta8.2 TCR peptides immunize against rat experimental allergic encephalomyelitis.

Authors:  Cristina Musselli; Svetlana Daverio-Zanetti; Maurizio Zanetti
Journal:  J Immune Based Ther Vaccines       Date:  2004-11-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.